Staining with lissamine green: a guide to dry eye

Article

Degree and pattern of staining with lissamine green is a good objective indicator of the severity of tear deficiency, according to a report published in the July issue of Eye and Contact Lens.

Degree and pattern of staining with lissamine green is a good objective indicator of the severity of tear deficiency, according to a report published in the July issue of Eye and Contact Lens.

James McCulley and colleagues from the University of Texas Southwestern Medical Center, USA found that the severity of dry eye correlates with the location of stain patterns. They examined the stain patterns in 22 patients with varying degrees of dry eye and in 11 patients with ocular disease who served as controls.

The researchers found that stains limited to the whites of the eyes between the lids toward the nose do not necessarily indicate dry eye but could be caused by environmental factors such as pollution. Stains that appear in the whites of the eye towards the ear are often symptomatic of dry eye. Finally, stains that appear on the cornea indicate a break in surface cells which can lead to serious bacterial infections.

The team suggested that these guidelines may allow for earlier diagnosis, allowing clinicians to offer more treatment options and preventing disease progression.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Related Content
© 2025 MJH Life Sciences

All rights reserved.